[The EHRA/HRS/APHRS/LAHRS/AEPC consensus statement on the management of atrial tachycardias : Implications of the SMART-AT 10-point plan for clinical practice and healthcare structures].

Q4 Medicine

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-03-26 DOI:10.1007/s00399-026-01148-3

Ann-Kathrin Kahle, Fares-Alexander Alken, Christoph Stellbrink, Stefan Perings, Lars Eckardt, Nikolaos Dagres, Christian Veltmann, Philipp Sommer, K R Julian Chun, Anja Schade, Shaojie Chen, Christian Perings, Maura M Zylla, Isabel Deisenhofer, Daniel Steven, Thomas Rostock, Stephan Willems, Christian Meyer

{"title":"[The EHRA/HRS/APHRS/LAHRS/AEPC consensus statement on the management of atrial tachycardias : Implications of the SMART-AT 10-point plan for clinical practice and healthcare structures].","authors":"Ann-Kathrin Kahle, Fares-Alexander Alken, Christoph Stellbrink, Stefan Perings, Lars Eckardt, Nikolaos Dagres, Christian Veltmann, Philipp Sommer, K R Julian Chun, Anja Schade, Shaojie Chen, Christian Perings, Maura M Zylla, Isabel Deisenhofer, Daniel Steven, Thomas Rostock, Stephan Willems, Christian Meyer","doi":"10.1007/s00399-026-01148-3","DOIUrl":null,"url":null,"abstract":"<p><p>Atrial tachycardias (AT) represent an increasingly common cause of morbidity and mortality. Driven by substantial advances in mapping and ablation technologies, the mechanistic understanding and therapeutic strategies for AT management have evolved rapidly in recent years, and catheter ablation is now regarded as the most effective strategy for maintaining sinus rhythm. Against this background, the recently published international clinical consensus statement on the management of patients with AT introduces, for the first time, a structured 10-point plan for \"SMART-AT care\" as a framework for the diagnosis and treatment of regular AT. This review highlights key developments and clinical implications, taking into account recent changes within the healthcare system.</p>","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"217-228"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Herzschrittmachertherapie und Elektrophysiologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00399-026-01148-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Atrial tachycardias (AT) represent an increasingly common cause of morbidity and mortality. Driven by substantial advances in mapping and ablation technologies, the mechanistic understanding and therapeutic strategies for AT management have evolved rapidly in recent years, and catheter ablation is now regarded as the most effective strategy for maintaining sinus rhythm. Against this background, the recently published international clinical consensus statement on the management of patients with AT introduces, for the first time, a structured 10-point plan for "SMART-AT care" as a framework for the diagnosis and treatment of regular AT. This review highlights key developments and clinical implications, taking into account recent changes within the healthcare system.

查看原文本刊更多论文

[EHRA/HRS/APHRS/LAHRS/AEPC关于房性心动过速管理的共识声明：SMART-AT 10点计划对临床实践和医疗结构的影响]。

心房心动过速（AT）是一种越来越常见的发病率和死亡率的原因。近年来，由于测绘和消融技术的巨大进步，对AT治疗的机制理解和治疗策略发展迅速，导管消融现在被认为是维持窦性心律最有效的策略。在此背景下，最近发表的关于AT患者管理的国际临床共识声明首次引入了一个结构化的“SMART-AT护理”10点计划，作为常规AT的诊断和治疗框架。这篇综述强调了关键的发展和临床意义，考虑到医疗保健系统最近的变化。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Herzschrittmachertherapie und Elektrophysiologie Medicine-Cardiology and Cardiovascular Medicine

CiteScore

1.10

自引率

0.00%

发文量

期刊介绍： Mit wissenschaftlichen Original- und Übersichtsarbeiten, Berichten über moderne Operationstechniken und experimentelle Methoden ist die Zeitschrift Herzschrittmachertherapie + Elektrophysiologie ein Diskussionsforum für Themen wie: - Zelluläre Elektrophysiologie - Theoretische Elektrophysiologie - Klinische Elektrophysiologie - Angewandte Herzschrittmachertherapie - Bradykarde und tachykarde Herzrhythmusstörungen - Plötzlicher Herztod und Risikostratifikation - Elektrokardiographie - Elektromedizinische Technologie - Experimentelle und klinische Pharmakologie - Herzchirurgie bei Herzrhythmusstörungen Mitteilungen der Arbeitsgruppen Herzschrittmacher und Arrhythmie der Deutschen Gesellschaft für Kardiologie - Herz und Kreislaufforschung e.V. (DGK) sowie Stellungnahmen und praktische Hinweise runden das breite Spektrum dieser Zeitschrift ab. Interessensgebiete: Kardiologie, Herzschrittmachertherapie, Herzschrittmachertechnologie, klinische Elektrophysiologie